Eli Lilly’s Mounjaro Won’t Have Separate Sleep Apnea Label in EU
Eli Lilly & Co.’s weight-loss and diabetes drug Mounjaro won’t be reclassified as a sleep apnea treatment in Europe, with ...
pulmonologyadvisor1h
Insulin Resistance Linked to Objective Excessive Daytime Sleepiness in OSA
Objective, but not subjective, EDS was associated with insulin resistance and disordered glucose metabolism among patients with OSA.
EU drugs regulator backs Mounjaro's sleep apnea use without fresh approval for Lilly
The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...
EMA says Lilly's weight-loss drug does not need separate approval for sleep apnea
The European Medicines Agency said on Friday Eli Lilly's weight-loss drug Mounjaro does not need a separate approval for the ...
Lilly's Mounjaro does not need separate indication for sleep apnea, EMA panel determines
Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...
pulmonologyadvisor15h
DORAs Improve Sleep Without Affecting AHI in Obstructive Sleep Apnea
without impairing respiratory function among patients with obstructive sleep apnea (OSA). These study findings, were published in the Journal of Sleep Research. Dual orexin receptor antagonists are ...
Hosted on MSN3d
Apple's Sleep Apnea Feature Gets FDA Approval: What Does It Means
Sleep apnea is a sleep disorder causing breathing lapses during sleep. Apple's sleep apnea detection feature represents a ...